Ambria Capital is an investment firm that focuses on investing in companies in the agriculture, consumer, healthcare, and technology industries. The company was founded in 2019 and is based in San Juan, Puerto Rico.
Healing Maps is a mental health platform established in 2020 and headquartered in Miami, Florida. The company focuses on providing education and information regarding psychedelic-assisted therapies, particularly those involving ketamine. It offers a variety of resources, including in-depth articles on medical psychedelics and a directory to locate nearby clinics. By delivering accurate and transparent information about psychedelic treatments, Healing Maps aims to empower individuals to understand their options and access the appropriate care for their mental wellness needs.
Tyson 2.0
Series A in 2022
Tyson 2.0 is a cannabis company founded by the renowned boxer and entrepreneur Mike Tyson. The company specializes in producing a diverse range of cannabis products, including full-spectrum cannabis flowers, concentrates, and consumables. With a commitment to purity and precision, Tyson 2.0 aims to provide consumers with high-quality products that are both premium and affordable. These offerings are widely accessible at retailers across the nation, ensuring that a broad audience can enjoy their products.
Wonder Sciences
Seed Round in 2022
Wonder Sciences operates a comprehensive ecosystem focused on mental health and wellness. It includes Wondermed, which collaborates with physicians to offer innovative psychedelic and somatic therapies for holistic healing. Wonder Clinics serve as mental health centers that provide psychedelic-assisted therapies alongside traditional medicine and advanced neuroscience techniques. Additionally, Wonder Research is dedicated to advancing clinical research through scientific studies aimed at establishing evidence-based protocols for psychedelic treatments. The company also features an online telemedicine platform that facilitates access to these therapies, allowing patients dealing with depression and anxiety to engage in safe, self-healing journeys from home.
Semasio
Series C in 2021
Semasio GmbH, founded in November 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to assist marketers in profiling and targeting internet users effectively. Its offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, which utilize Natural Language Processing to analyze website content and create detailed user profiles. This enables clients, including global agency networks and advertisers, to identify specific target audiences and optimize their advertising strategies. Semasio's platform supports real-time advertising and provides tools for managing data ownership and transparency. With additional development centers in Denmark and Portugal, Semasio aims to enhance advertising efficiency while adhering to privacy standards.
MycroDose Therapeutics
Seed Round in 2021
MycroDose Therapeutics is a U.S.-based pharmaceutical company focused on developing advanced drug delivery systems that utilize psychedelic compounds for the treatment of mental health disorders and cognitive degenerative diseases. The company is actively working on two of its four core technologies, which include a psilocybin transdermal delivery system and a ketamine oral mucosa delivery system. By leveraging these innovative approaches, MycroDose Therapeutics aims to enhance the efficacy and accessibility of treatments for patients dealing with these challenging conditions.
NanoPsy
Seed Round in 2021
NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.
WeSana Health
Post in 2021
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.
WeSana Health
Convertible Note in 2021
WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.